June 12, 2024
The American College of Radiology ® (ACR®) submitted comments June 6, in response to the fiscal year (FY) 2025 Hospital Inpatient Prospective Payment System (IPPS) proposed rule. The Centers for Medicare and Medicaid Services (CMS) requested stakeholder feedback on determining newness for technologies that use artificial intelligence (AI) software for New Technology Add-on Payments (NTAP).

ACR urged CMS to consider establishing a distinct, high-value AI-specific alternative NTAP pathway that would determine uniqueness based on whether the technology enables a clinically valuable task for Medicare beneficiaries not previously achievable without technology. The U.S. Food and Drug Administration currently is not required to consider a product’s value to the Medicare population as part of the Breakthrough Device designation. The College believes that value should not only be considered, but guided by input from physician experts and specialty communities for ongoing evaluations.

If you have questions, please contact Kimberly Greck, ACR Senior Economic Policy Analyst.

Related ACR News

  • Urge Your Representative to Cosponsor ROOT Act Today

    ACR urges support for H.R. 5737, the ROOT Act, to fix CMS imaging rules and save Medicare billions. Contact your rep to cosponsor today.

    Read more
  • ACR Urges Commerce to Protect Access to Radiology Devices

    ACR urges Commerce to avoid tariffs on imaging tech, warning it could harm patient access, raise care costs, and strain the U.S. healthcare system.

    Read more
  • Federal Government Shutdown: Key Updates

    Key information and resources for ACR members regarding the October 2025 U.S. federal government shutdown.

    Read more